Overview

Open-Label Extension Study to Evaluate Long Term Safety and Treatment Effect of DiaPep277®

Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
This is an extension study to evaluate the safety and tolerability of long-term treatment with DiaPep277® and to determine the long-term treatment effect of DiaPep277® on parameters of metabolic control and on preservation of beta-cell function in subjects who have long exposure to DiaPep277®.
Phase:
Phase 3
Details
Lead Sponsor:
Andromeda Biotech Ltd.